<!DOCTYPE html>
<html lang="en-US"><head>
		<meta charset="UTF-8">
		<title>FR940627-0-00254</title>
	</head>
	<body>
		<main>
			<p><!-- PJG STAG 4700 -->  <!-- PJG ITAG l=11 g=1 f=1 --> (4)  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> Test evaluation. <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  (i) A positive result in the  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> in vivo <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  SCE assay for either,  <!-- PJG 0012 frnewline --> or both, the lung or lymphocyte cultures indicates that under the  <!-- PJG 0012 frnewline --> test conditions the test substance induces reciprocal  <!-- PJG 0012 frnewline --> interchanges of DNA in duplicating chromosomes from lung or  <!-- PJG 0012 frnewline --> lymphocyte cells of the test species.  <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline --> (ii) Negative results indicate that under the test  <!-- PJG 0012 frnewline --> conditions the test substance does not induce reciprocal  <!-- PJG 0012 frnewline --> interchanges in lung or lymphocyte cells of the test species.  <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline --> (5)  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> Test report. <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  In addition to the reporting  <!-- PJG 0012 frnewline --> recommendations as specified under &sect;&sect;79.60 and 79.61, the  <!-- PJG 0012 frnewline --> following specific information shall be reported:  <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline --> (i) Test concentrations used, rationale for concentration  <!-- PJG 0012 frnewline --> selection, negative and positive controls;  <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline --> (ii) Toxic response data by concentration;  <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline --> (iii) Schedule of administration of test atmosphere, BrdU,  <!-- PJG 0012 frnewline --> and spindle inhibitor;  <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline --> (iv) Time of harvest after administration of BrdU;  <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline --> (v) Identity of spindle inhibitor, its concentration and  <!-- PJG 0012 frnewline --> timing of treatment;  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> (vi) Details of the protocol used for cell culture and  <!-- PJG 0012 frnewline --> slide preparation;  <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline --> (vii) Criteria for scoring SCE;  <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline --> (viii) Replicative index,  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> i.e., <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  [percent 1st division+(2&times;percent 2nd division) + (3&times;percent 3rd division)  <!-- PJG 0012 frnewline --> metaphases]/100; and  <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline --> (ix) Mitotic activity,  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> i.e., <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->   <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=6 f=1 --> # <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  of metaphases/1000 cells.  <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline --> (f)  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> References. <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  For additional background information on  <!-- PJG 0012 frnewline --> this test guideline, the following references should be consulted.  <!-- PJG /ITAG -->  <!-- PJG QTAG 04 --> <!-- PJG /QTAG -->  <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline -->  <!-- PJG ITAG l=21 g=1 f=1 --> (1) 40 CFR 798.5915,  <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=3 --> In vivo <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=1 -->  Sister Chromatid Exchange  <!-- PJG 0012 frnewline --> Assay.  <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline --> (2) Kato, H. ``Spontaneous Sister Chromatid Exchanges  <!-- PJG 0012 frnewline --> Detected by a BudR-Labeling Method.'' Nature, 251:70&hyph;72 (1974).  <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline --> (4) Kligerman, A. D.,  <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=3 --> et al. <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=1 -->  ``Sister Chromatid Exchange  <!-- PJG 0012 frnewline --> Analysis in Lung and Peripheral Blood Lymphocytes of Mice Exposed  <!-- PJG 0012 frnewline --> to Methyl Isocyanate by Inhalation.'' Environmental Mutagenesis  <!-- PJG 0012 frnewline --> 9:29&hyph;36 (1987).  <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline --> (5) Kligerman, A.D.,  <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=3 --> et al., <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=1 -->  ``Cytogenetic Studies of  <!-- PJG 0012 frnewline --> Rodents Exposed to Styrene by Inhalation'', IARC Monographs no.  <!-- PJG 0012 frnewline --> 127 ``Butadiene and Styrene: Assesment of Health Hazards'' (Sorsa,  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=3 --> et al <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=1 --> ., eds), pp 217&hyph;224, 1993.  <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline --> (6) Kligerman, A.,  <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=3 --> et al., <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=1 -->  ``Cytogenetic Studies of Mice  <!-- PJG 0012 frnewline --> Exposed to Styrene by Inhalation.'', Mutation Research, 280:35&hyph;43,  <!-- PJG 0012 frnewline --> 1992.  <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline --> (7) Wolff, S., and P. Perry. ``Differential Giemsa  <!-- PJG 0012 frnewline --> Staining of Sister Chromatids and the Study of Sister Chromatid  <!-- PJG 0012 frnewline --> Exchanges Without Autoradiography.'' Chromosoma 48: 341&hyph;53 (1974).  <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=80 g=1 f=1 --> &sect;79.66  <!-- PJG /ITAG -->  <!-- PJG ITAG l=89 g=1 f=1 --> Neuropathology assessment.  <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> (a)  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> Purpose. <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  (1) The histopathological and biochemical techniques in  <!-- PJG 0012 frnewline --> this guideline are designed to develop data in animals on  <!-- PJG 0012 frnewline --> morphologic changes in the nervous system associated with  <!-- PJG 0012 frnewline --> repeated inhalation exposures to motor vehicle emissions. These  <!-- PJG 0012 frnewline --> tests are not intended to provide a detailed evaluation of  <!-- PJG 0012 frnewline --> neurotoxicity. Neuropathological evaluation should be  <!-- PJG 0012 frnewline --> complemented by other neurotoxicity studies, e.g. behavioral and  <!-- PJG 0012 frnewline --> neurophysiological studies and/or general toxicity testing, to  <!-- PJG 0012 frnewline --> more completely assess the neurotoxic potential of an exposure.  <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline --> (2) [Reserved] <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> (b)  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> Definition. <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  Neurotoxicity (NTX) or a neurotoxic effect  <!-- PJG 0012 frnewline --> is an adverse change in the structure or function of the nervous  <!-- PJG 0012 frnewline --> system following exposure to a chemical substance.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG /STAG --></p>
		</main>
</body></html>
            